849217-48-7,
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid,
1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid,
1-[(4-fluorophenyl)carbamoyl]cyclopropane-1-carboxylic acid,
1-[(4-fluorophenyl)carbamoyl]cyclopropanecarboxylic acid,
Cyclopropanecarboxylic acid, 1-[[(4-fluorophenyl)amino]carbonyl]-,
1-(4-fluoro-phenylcarbamoyl)-cyclopropanecarboxylic acid,
1-(4-fluoro-phenylcarbamoyl}-cyclopropanecarboxylic acid,
1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxylic acid,
AC1Q71YI,
InterMediate of Cabozantinib,
SCHEMBL105644,
CTK3C9655,
KS-00000OUB,
DTXSID00610608,
PFMAFXYUHZDKPY-UHFFFAOYSA-N,
BCP15333,
ANW-46787,
CF0049,
MFCD11226313,
ZINC21304711,
AKOS008151310,
CS-W019220,
MCULE-7223722366,
MP-0467,
QC-2700,
RL05227,
SB17898,
AC-29722,
AJ-78557,
AK-54049,
DS-14316,
SY047869,
AB0026994,
TC-135532,
4CH-010570,
F1083,
FT-0701258,
ST24020966,
W8765,
EN300-58849,
MFCD11226313 (95%),
TL800742134,
J-503319,
((4-fluorophenyl)carbamoyl)cyclopropanecarboxylic acid,
1-(4-fluorophenylcarbamoyl)-cyclopropanecarboxylic acid,
Z1259041011,
1-((4-fluorophenyl)carbamoyl) -cyclopropanecarboxylic acid,
1-((4-fluorophenyl)carbamoyl)-cyclopropanecarboxylic acid,
1-((4-fluorophenyl)carbamoyl)cyclopropane carboxylic acid,
1-(4-fluorophenylaminocarbonyl)cyclopropanecarboxylic acid,
1-{[(4-fluorophenyl)amino]carbonyl}cyclopropanecarboxylic acid,
C11H10FNO3,
ACN-050757,
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylicacid,